Key facts
- Norm’s last known valuation is $84.0M (Mar 2023).
- It has raised $206.1M; the latest was Later Stage VC ($120.0M) in Jan 2025.
- Notable investors include New Enterprise Associates, Novo Holdings, Polaris Partners, Sands Capital, Andera Partners — 14 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 14 names
- ·Watchlist + deal alerts for Norm
- ·The full record, as it builds
Funding rounds
No funding rounds for Norm are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Norm
Developer of a remote monitoring device designed to improve heart failure patients' lives through remote monitoring technology. The company offers a novel remote monitoring system that provides healthcare providers with real-time patient data and insights, enabling early detection of heart failure complications, proactive interventions, and improved patient outcomes.
- Sector
- Healthcare
- HQ
- Dublin, Ireland
- Founded
- 2013
- Employees
- 86
- Website
- fire1foundry.com/
- Ownership
- Privately Held (backing)
Norm doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Norm shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Norm in its N-PORT filings yet. We sweep new filings monthly.